1. Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer
   Dongxing Ji et al, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. Cannabinoids for Neurological Conditions
   Baye G. Williamson et al, 2021, Cannabis Therapy in Veterinary Medicine CrossRef
3. Shiga toxin-2 enhances heat-shock-induced apoptotic cell death in cultured and primary glial cells
   Naotoshi Sugimoto et al, 2014, Cell Biology and Toxicology CrossRef
4. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
   Shuanglin Deng et al, 2014, Protein & Cell CrossRef
5. The evolving role of the endocannabinoid system in gynaecological cancer
   Thangesweran Ayakannu et al, 2015, Human Reproduction Update CrossRef
6. Cannabinoids as therapeutic agents in cancer: current status and future implications
   Bandana Chakravarti et al, 2014, Oncotarget CrossRef
7. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
   Rebecca J. Henry et al, 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
8. Theobromine, the Primary Methylxanthine Found inTheobroma cacao, Prevents Malignant Glioblastoma Proliferation by Negatively Regulating Phosphodiesterase-4, Extracellular Signal-regulated Kinase, Akt/mammalian Target of Rapamycin Kinase, and Nuclear Factor-Kappa B
   Naotoshi Sugimoto et al, 2014, Nutrition and Cancer CrossRef
9. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
   Kathleen L. McCoy, 2016, Mediators of Inflammation CrossRef
10. Corticosterone inhibits the expression of cannabinoid receptor‑1 and cannabinoid receptor agonist‑induced decrease in cell viability in glioblastoma cells
    Naotoshi Sugimoto et al, 2019, Oncology Letters CrossRef
11. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
    John-Mark K. Fitzpatrick et al, 2017, Neuropharmacology CrossRef
12. Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
    Yang Xun et al, 2021, Journal of Hematology & Oncology CrossRef
13. Oxidative Stress and Autophagy Mediate Anti-Cancer Properties of Cannabis Derivatives in Human Oral Cancer Cells
    Lionel Loubaki et al, 2022, Cancers CrossRef
14. Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
    Austin R. Jackson et al, 2014, PLoS ONE CrossRef
15. Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
    Abdul Samad Basheer et al, 2021, Cancers CrossRef
16. Effects of Peptidoglycan, Lipoteichoic Acid and Lipopolysaccharide on Inflammation, Proliferation and Milk Fat Synthesis in Bovine Mammary Epithelial Cells
    Yongjiang Wu et al, 2020, Toxins CrossRef
17. Endocannabinoid signaling in glioma
    Carlos Costas‐Insua et al, 2023, Glia CrossRef
18. HYPOXIA DOWNREGULATES CANNABINOID RECEPTORS, UPREGULATES COX-2, AND ATTENUATES CANNABINOID RECEPTOR AGONIST-INDUCED CELL DEATH IN GLIOBLASTOMA CELLS
    Naotoshi Sugimoto et al, 2018, Pathophysiology CrossRef
19. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review
    Ismini Kyriakou et al, 2021, Phytomedicine CrossRef
20. PD-L1/PD-1 Axis in Glioblastoma Multiforme
    Jakub Litak et al, 2019, International Journal of Molecular Sciences CrossRef
21. Toll-like receptor signalling as a cannabinoid target
    Melody Cui Sun et al, 2024, Biochemical Pharmacology CrossRef
22. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
    Caroline Turcotte et al, 2015, Journal of Leukocyte Biology CrossRef